News

news: JBEI's Keasling Elected to National Academy of Inventors

JBEI's Keasling Elected to National Academy of Inventors

JBEI's CEO Jay Keasling was among 170 new fellows, recognized by the National Academy of Investors for outstanding contributions to innovation in patents and licensing, innovative discovery and technology, significant impact on society, and support and enhancement of innovation.

December 19, 2014

news: Sweet Smell of Success: JBEI Researchers Boost Methyl Ketone Production in E. coli
news: New Lab Startup Afingen Uses Precision Method to Enhance Plants

New Lab Startup Afingen Uses Precision Method to Enhance Plants

By manipulating a plant’s metabolic pathways, JBEI's Henrik Scheller and Dominique Loqué, have figured out a way to genetically rewire plants to allow for an exceptionally high level of control over the spatial pattern of gene expression, while at the same time boosting expression to very high levels.

October 29, 2014

news: Boosting Biogasoline Production in Microbes
news: JBEI Researchers Harness Power of Microbes for Work and Winemaking

JBEI Researchers Harness Power of Microbes for Work and Winemaking

Scientists Chris Petzold (left) and Trent Northen have put their doctorates in chemistry to work in their JBEI research and in their free time, where they’ve applied their interest in the science of soil, plants, and microbes to wine making. The results thus far have been impressive and enjoyable.

October 08, 2014

news: MaxBin: Automated Sorting Through Metagenomes

MaxBin: Automated Sorting Through Metagenomes

Researchers at JBEI led by Steve Singer, director of the Microbial Communities Group, have developed an automated software program for sorting the genomes of individual microbial species from metagenomic sequences. MaxBin facilitates the genomic analysis of uncultivated microbial populations that can hold the key to the production of advanced biofuels and other products.

September 29, 2014

news: The Economist Recognizes JBEI’s CEO Jay Keasling for Anti-Malarial Effort

The Economist Recognizes JBEI’s CEO Jay Keasling for Anti-Malarial Effort

On Sept. 10, The Economist announced JBEI’s CEO Jay Keasling as the winner of its 2014 Innovation Award in the Bioscience category. In addition to being JBEI’s CEO, Keasling is a Professor of Chemical Engineering at the University of California, Berkeley and Senior Faculty Scientist and Associate Lab Director at Berkeley Lab. He was recognized for his development of synthetic artemisinin used to treat malaria.

September 10, 2014

news: JBEI’s CSTO Blake Simmons nominated as EMSL Wiley Research Fellow
news: JBEI staff among recipients of the 2014 Berkeley Lab Director’s Awards for Exceptional Achievement
news: Bionic Liquids from Lignin